Table 1.
List of top 5 significantly enriched GO terms and KEGG pathways of DEGs.
| Category | GO ID | Description | Gene Count | Adjusted p-Value |
|---|---|---|---|---|
| BP | GO:0048731 | system development | 83 | 8.49 × 10−4 |
| BP | GO:0032502 | developmental process | 100 | 1.82 × 10−3 |
| BP | GO:0051128 | regulation of cellular component organisation | 51 | 2.13 × 10−3 |
| BP | GO:0022617 | extracellular matrix disassembly | 8 | 3.78 × 10−3 |
| BP | GO:0048518 | positive regulation of biological process | 96 | 4.18 × 10−3 |
| CC | GO:0015629 | actin cytoskeleton | 21 | 2.33 × 10−5 |
| CC | GO:0042641 | actomyosin mesenchymal transition | 9 | 4.31 × 10−5 |
| CC | GO:0005615 | extracellular space | 62 | 1.37 × 10−3 |
| CC | GO:0005576 | extracellular region | 73 | 3.08 × 10−3 |
| CC | GO:0005884 | actin filament | 8 | 1.08 × 10−2 |
| MF | GO:0043394 | proteoglycan binding | 7 | 3.46 × 10−5 |
| MF | GO:0050840 | extracellular matrix binding | 6 | 1.24 × 10−2 |
| MF | GO:0005515 | protein binding | 156 | 1.98 × 10−2 |
| KEGG | KEGG:05166 | human T-cell leukaemia virus 1 infection | 11 | 5.68 × 10−3 |
| KEGG | KEGG:04110 | cell cycle | 8 | 1.16 × 10−2 |
| KEGG | KEGG:05200 | pathways in cancer | 17 | 1.99 × 10−2 |